Prevalence of CCR5-tropic HIV-1 among treatment-experienced individuals in Spain

HIV Clinical Trials
MorenoAllegro Study Group

Abstract

To determine the prevalence of CCR5-tropic HIV-1 among treatment-experienced patients in Spain. Epidemiologic, cross-sectional, and non-interventional study between January and June 2008 in HIV-1-infected patients in Spain. A total of 485 treatment-experienced patients from across Spainand with a plasma viral load of not greater-than1000 copies/mL were studied. Viral tropism, CD4+ cell count, plasma viral load, stage of disease, and current treatment strategies were determined. Univariate and multivariate logistic regression analyses were used to determine association of coreceptor use with patients' characteristics. Coreceptor usage was determined by viral tropism assays: 290 (68.9%) patients had CCR5-tropic HIV-1 virus, and 131 (31.1%) had dual-tropic/mixed or CXCR4 virus variants. Mean CD4+ cell counts in the R5 group (319.4 cells/mm3) were higher than in the non-R5 group (237.9 cells/mm3) (p = .0005). There was an inverse relationship between CD4+ cell counts and plasma viral load, but regression analyses on covariates associated with CCR5 tropism showed that only a higher CD4+ cell number was significantly associated with CCR5 coreceptor usage. The prevalence of CCR5-tropic HIV-1 among treatment-experienced patients in Spa...Continue Reading

References

May 1, 1994·The Journal of Infectious Diseases·D D Richman, S A Bozzette
May 2, 2003·Nature Biotechnology·Debra Robertson
Jan 14, 2005·Current Opinion in Infectious Diseases·Eoin CoakleyJeannette M Whitcomb
Feb 18, 2005·The Journal of Infectious Diseases·Graeme J MoyleBrian G Gazzard
Mar 15, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Pierre DelobelJacques Izopet
Jul 5, 2005·The Journal of Infectious Diseases·Zabrina L BrummeP Richard Harrigan
Sep 9, 2006·The Journal of Infectious Diseases·Peter W HuntSteven G Deeks
Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy J WilkinRoy M Gulick
Dec 8, 2007·The Journal of Antimicrobial Chemotherapy·Verónica BrizVincent Soriano
Jun 14, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman
Aug 12, 2008·Current Gene Therapy·Reza Nazari, Sadhna Joshi
Oct 4, 2008·The New England Journal of Medicine·Roy M GulickUNKNOWN MOTIVATE Study Teams
Feb 6, 2009·Drugs·Birgitt Dau, Mark Holodniy
Aug 13, 2009·The Journal of Antimicrobial Chemotherapy·Miguel GenebatManuel Leal

❮ Previous
Next ❯

Citations

Mar 15, 2013·Journal of Clinical Microbiology·Jan WeberMiguel E Quiñones-Mateu
Mar 25, 2011·The Lancet Infectious Diseases·L P R VandekerckhoveUNKNOWN European Consensus Group on clinical management of tropism testing
Sep 15, 2011·Journal of Medical Virology·Milosz ParczewskiAnna Boron-Kaczmarska
Nov 21, 2012·PloS One·John ArcherMiguel E Quiñones-Mateu
Apr 20, 2010·Foot & Ankle Specialist·Christopher F Hyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.